Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies.
<h4>Background</h4>We systematically analyzed multiple myeloma (MM) cell lines and patient bone marrow cells for their engraftment capacity in immunodeficient mice and validated the response of the resulting xenografts to antimyeloma agents.<h4>Design and methods</h4>Using fl...
Guardado en:
Autores principales: | Julia Schueler, Dagmar Wider, Kerstin Klingner, Gabrielle M Siegers, Annette M May, Ralph Wäsch, Heinz-Herbert Fiebig, Monika Engelhardt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/084d0622fa22403885cc394eda0e439b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antibody repertoires in humanized NOD-scid-IL2Rγ(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse.
por: Gregory C Ippolito, et al.
Publicado: (2012) -
Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγnull mice treated with alogliptin
por: Jurczyk A, et al.
Publicado: (2013) -
NOD/scid IL‐2Rγnull mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotype
por: Anna‐Lena Unterweger, et al.
Publicado: (2021) -
Human delta like 1-expressing human mesenchymal stromal cells promote human T cell development and antigen-specific response in humanized NOD/SCID/IL-2R $$\upgamma $$ γ null (NSG) mice
por: Do Hee Kwon, et al.
Publicado: (2021) -
Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models
por: Miao Miao, et al.
Publicado: (2021)